Latest Regulatory Approvals News

Central Iron Ore Limited has announced a rights offering to raise up to $2.89 million, aiming to support its South Darlot joint venture, advance drilling at British King Mine, and repay a loan to majority shareholder Gullewa Limited.

Javelin Minerals has lodged its Mining Proposal for the Eureka Gold Project, setting the stage for mining to commence in mid-2026 and first cashflow by Q3. Fully funded and partnered with MEGA Resources, the project is on track to unlock value in Western Australia’s prolific goldfields.

Theta Gold Mines has entered a non-binding agreement for an $80 million USD senior secured loan to fully fund its TGME Gold Mine Project, aiming for first gold pour in early 2027. The deal includes flexible funding tranches and equity-linked warrants.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.

Li-FT Power Ltd has announced a strategic acquisition of Winsome Resources Limited and plans to acquire a controlling interest in the Galinée lithium property, aiming to create a leading Canadian lithium developer with enhanced scale and market presence.

Zeus Resources has secured Forestry Department approval to begin trenching at its Casablanca Antimony Project in Morocco, clearing a key regulatory hurdle for exploration. The program aims to refine geological understanding and target high-grade antimony mineralization.

4DMedical has gained Canadian regulatory approval for its innovative CT – VQ™ ventilation-perfusion imaging technology, enabling immediate commercial rollout through Philips and expanding its North American footprint.

Echelon Resources has signed a term sheet with the Northern Territory’s Power and Water Corporation to supply gas through 2034, including plans for four new wells that could significantly increase output from the Amadeus Basin.

Radiopharm Theranostics reports promising interim Phase 2b results for RAD 101, achieving 92% concordance with MRI in detecting brain metastases, paving the way for a pivotal study in 2026.

Diatreme Resources has submitted the Draft Environmental Impact Statement for its Northern Silica Project, marking a significant step toward regulatory approval and highlighting its potential to boost regional economies and support global solar energy growth.

Prescient Therapeutics has secured European authorization to initiate a Phase 2a clinical trial of its novel cancer drug PTX-100 for relapsed/refractory Cutaneous T-cell Lymphoma, enabling trial site activation in Italy.